Towards a human oral vaccine for anthrax: The utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy

This publication has 37 references indexed in Scilit:

• Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect againstBacillus anthracisInfection and Enhance Endogenous Immunity to Anthrax
  Infection and Immunity, 2007
• Enhanced Immunity toPlasmodium falciparumCircumsporozoite Protein (PfCSP) by UsingSalmonella entericaSerovar Typhi Expressing PfCSP and a PfCSP-Encoding DNA Vaccine in a Heterologous Prime-Boost Strategy
  Infection and Immunity, 2007
• Oral Administration of a Salmonella enterica -Based Vaccine Expressing Bacillus anthracis Protective Antigen Confers Protection against Aerosolized B. anthracis
  Infection and Immunity, 2007
• Immunogenicity of Recombinant Protective Antigen and Efficacy against Aerosol Challenge with Anthrax
  Infection and Immunity, 2005
• Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy
  Vaccine, 2004
• Salmonella enterica Serovar Typhimurium Expressing a Chromosomally Integrated Copy of the Bacillus anthracis Protective Antigen Gene Protects Mice against an Anthrax Spore Challenge
  Infection and Immunity, 2003
• Salmonellavaccines for use in humans: present and future perspectives
  FEMS Microbiology Reviews, 2002
• Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracis Protective Antigen Protects against Anthrax Infection in Mice
  Infection and Immunity, 2002
• Delivering death in the mail
  Nature, 2001
• Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis
  Letters in Applied Microbiology, 1998